Haoxi Health Technology Limited Class A Ordinary Shares is a pioneering force in the health technology sector, committed to revolutionizing healthcare delivery through innovative solutions. Utilizing advanced technologies like artificial intelligence and data analytics, the company aims to enhance diagnosis, treatment efficiency, and patient management, setting new standards in healthcare practices. With a robust focus on research and development, Haoxi is well-positioned to capitalize on emerging trends in the healthcare technology landscape, presenting a significant growth opportunity for institutional investors.
| Revenue (TTM) | $32.80M |
| Gross Profit (TTM) | 927,750 |
| EBITDA | $-1.71M |
| Operating Margin | -21.20% |
| Return on Equity | 27.10% |
| Return on Assets | -6.74% |
| Revenue/Share (TTM) | $14.05 |
| Book Value | $6.00 |
| Price-to-Book | 3.46 |
| Price-to-Sales (TTM) | 1.85 |
| EV/Revenue | 1.629 |
| EV/EBITDA | 11.71 |
| Quarterly Earnings Growth (YoY) | 172.70% |
| Quarterly Revenue Growth (YoY) | -64.60% |
| Shares Outstanding | $58.75M |
| Float | $2.84M |
| % Insiders | 0.73% |
| % Institutions | 0.07% |